Circulation

American Heart Association releases new scientific statement on obesity and cardiovascular disease

U.S. Preventive Services Task Force

New draft recommendations for prediabetes, type 2 diabetes screening released by U.S. Preventive Services Task Force

Journal of the American College of Cardiology

The American COVID-19 Myocardial Infarction Registry shows that MI patients with COVID-19 have a really poor prognosis

JAMA

New study examines patient disparities with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US

Diabetes Care

DKA rates in pediatric type 2 diabetes have significantly increased during the COVID-19 pandemic

Science Direct

New case report examines new presentations of DKA, COVID-19, and cardiac arrhythmias in children and adolescents with T2D

CMHC Spring Clinical Highlights

The 2021 CMHC Spring concluded on Sunday, April 18— delivering two and a half days of critically curated content and expert perspectives on the management of cardiometabolic disease and cardiometabolic risk, as well as special sessions on the impact of COVID-19 on cardiometabolic disease.

Review the clinical highlights discussed during the event in our clinical highlights packet below.

Interview with Dr. Chip Lavie

Dr. Carl Lavie, Professor of Medicine and Medical Director of Cardiac Rehabilitation and Prevention, as well as Director of Stress Testing Laboratory at John Ochsner Heart and Vascular Institute in New Orleans, LA discusses the impacts of COVID-19 in obesity management.

Also available on:

Don't forget to subscribe and leave us a review wherever you listen to your podcasts!